Azura Ophthalmics focuses on the development of ophthalmic keratolytics for the treatment of ocular conditions.

Azura Ophthalmics

Biogénesis Bagó focuses on animal health globally. The company provides solutions for both large and companion animals, as self-described.

Biogénesis Bagó

Grin Eye Care provides comprehensive eye care services, including cataract surgery, laser vision correction, and products like glasses and contacts. The company is self-described as dedicated to meeting all ophthalmology needs.

Grin Eye Care

Lumenis is a global leader in developing and commercializing energy-based solutions for the Aesthetic and Vision markets. With over 50 years of industry leadership and innovation, Lumenis creates and commercializes innovative energy-based technologies that enable a variety of skin, body, and eye care treatments. The company has a strong global presence, with an active installed base of more than 80,000 systems and sales in over 100 countries.

Metric
Company Name	Azura Ophthalmics	Biogénesis Bagó	Grin Eye Care	Lumenis
Symbol
MSH ID	COM:AZURAOPHTHALMICS	COM:BIOGENESISBAGO	COM:GRINEYECARE	COM:LUMENIS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biopharmaceuticals	Veterinary Medicine	Healthcare	Medical Devices
Country	US	AR	US
Stage
Employee Count			11	501
Website	azuraophthalmics.com	biogenesisbago.com	grineyecare.com	lumenis.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			3.26K
Web Traffic Growth			10.82
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:AZURAOPHTHALMICS

Azura Ophthalmics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue